Arizona Biltmore

March 1 & 2, 2024



Desert Liver Retreat

We provide a superior scientific program and a fun opportunity to network with colleagues seeking an update in state-of-the-art liver disease care. Our exhibitors are chosen as excellent providers of important products and services to our community.

Target Audience

This event is intended for MDs, DOs, PAs, NPs, RNs, residents, fellows, and clinical research personnel who are involved in the care of patients with liver disease.

Educational Objectives

After attending this event the participant should be better able to:

  • Utilize most recent guidelines for screening and diagnosing patients at risk of chronic liver disease

  • Develop an evidence-based treatment regimen for chronic liver disease using latest clinical evidence

  • Communicate disease and treatment options to patients

  • Recognize and communicate risks and benefits of therapy

  • Recognize differential diagnosis for NAFLD & NASH

  • Characterize risk factors for PBC & be able to discuss different therapies for PBC

  • Identify diagnostic approaches for HCC and treatment options

  • Explain diagnostic criteria and diagnostic tools for minimal and overt HE

  • Define diagnostic and therapeutic strategies for HCC

  • Demonstrate understanding of the diagnostic approaches for PSC and the role of liver biopsy as well as what therapies are used for PSC and when

  • Demonstrate understanding of different currently available treatment options for different clinical manifestations of portal hypertension

  • Choose different interventions and treatment approaches to minimize inpatient health care utilization for patients with liver disease

  • Describe the hepatic manifestations of COVID-19 infections including acute hepatic injury and cholangitis

Accreditation Statements

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Arizona Liver Health.  Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

The Postgraduate Institute for Medicine designates this live for a maximum of 10.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 10.25 medical knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Continuing Nursing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 10.25 contact hours.

Continuing Physician Assistant Education

Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 10.25 AAPA Category 1 CME credits.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

2024 Agenda

Friday, March 1 - Steatotic Liver Disease Summit/ Noninvasive Tests (NITs) Workshop

1:00 PM - 1:05 PM

Opening Remarks

Stephen Harrison, MD, FACP, FAASLD

1:05 PM - 1:30 PM

Imaging NITs (Non-Invasive Imgaing Technologies)

Mazen Noureddin, MD, MHSc

1:30 PM - 1:55 PM

Serologic NITs

Meena Bansal, MD

1:55 PM - 2:20 PM

Selecting Patients for Treatment and Monitoring Response

Stephen Harrison, MD, FACP, FAASLD

2:20 PM - 2:50 PM

Interactive Cases

Naim Alkhouri, MD, FAASLD

2:50 PM- 3:10 PM


3:10 PM - 4:30 PM

NITs Demonstration (Aegle Medical-Mindray/ Echosens/ e-Scopics/ Soniclncytes)

4:30 PM - 5:15 PM

Panel Discussion on the Future of MASH Therapeutics

Naim Alkhouri, MD, FAASLD
Meena Bansal, MD
Stephen Harrison, MD, FACP, FAASLD
Mazen Noureddin, MD, MHSc

Saturday, March 2 - Agenda

7:00 AM - 8:30 AM

Registration, Exhibits, & Breakfast

7:15 AM - 8:00 AM

Product Theater - Madrigal & Breakfast

8:00 AM - 8:30 AM

Exhibits & Breakfast

8:30 AM - 8:35 AM

Opening Remarks

Naim Alkhouri, MD, FAASLD

8:35 AM - 9:00 AM

Drug Induced Liver Injury

Raj Vuppalanchi, MD

9:00 AM - 9:25 AM

Management of the Forgotten Symptoms of Cirrhosis: From Sarcopenia to Cramps and Beyond

Elliot Tapper, MD

9:25 AM - 9:50 AM

Liver Transplant for the Non-Specialist

Moises (IIan) Nevah Rubin, MD

9:50 AM - 10:05 AM

Panel Discussion

Moderator: Stephen Harrison, MD, FACP, FAASLD Panelists: Raj Vuppalanchi, MD
Elliot Tapper, MD
Moises (IIan) Nevah Rubin, MD

10:05 AM - 10:20 AM

Break & Exhibits

10:20 AM - 10:45 AM

Steatotic Liver Desease (SLD) New Nomenclature: Implications and Implementation

Meena Bansal, MD

10:45 AM - 11:10 AM

All You Need to Know on Diagnosing MASLD: From Risk Stratification to Treatment Monitoring

Mazen Noureddin. MD

11:10 AM - 11:35 AM

Management of MASH with New Drugs: The Future is Bright

Stephen Harrison, MD, FACP, FAASLD

11:30 AM - 12:00 P5

Practical SLD Cases and Panel Discussion

Naim Alkhouri, MD, FAASLD

12:00 PM - 12:15 PM

Panel Discussion

Moderator: Naim Alkhouri, MD, FAASLD, ABOM Panelists: Meena Bansal, MD
Mazen Noureddin, MD
Stephen Harrison, MD

12:15 PM - 12:45 PM

Lunch & Exhibits

12:45 PM - 1:15 PM

Product Theater - Ipsen & Lunch

1:15 PM - 1:45 PM

Lunch & Exhibits

1:45 PM - 2:10 PM

Treatment for HBV/HDV: Are we Close to a Cure?

Julio Gutierrez, MD

2:10 PM - 2:35 PM

HCV Elimination: Where are we?

Anita Kohli, MD

2:35 PM - 3:00 PM

PBC Update: New Drugs Coming Your Way Soon

Raj Vuppalanchi, MD

3:00 PM - 3:25 PM

Genetic Cholestasis for the Adult Provider

Naim Alkhouri, MD, FAASLD

3:25 PM - 3:40 PM

Panel Discussion

Moderator: Anita Kholi, MD
Panelists: Julio Gutierrez, MD
Raj Vuppalanchi, MD
Naim Alkhouri, MD, FAASLD, ABOM

3:40 PM - 3:55 PM

Break & Exhibits

3:55 PM - 4:20 PM

Cirrhosis/ Portal Hypertension Update: From HRS to HCC

Jacqueline O'Leary, MD, MPH

4:20 PM - 4:45 PM

The Big 3 of Genetic Liver Diseases: Hemochromatosis/ A1ATD/ Wilson Disease

Richard Manch, MD, FAASLD, FACP, FACG

4:45 PM - 5:00 PM

Panel Discussion

Moderator: Jasqueline O' Leary, MD, MPH
Panelists: Richard Manch, MD, FAASLD, FACP, FACG, Naim Alkhouri, MD, FAASLD, ABOM

5:00 PM

Closing Remarks

Anita Kholi, MD
Naim Alkhouri, MD, FAASLD, ABOM

Reception to Follow for Registered Attendees and Sponsors

Course Directors

2024 Desert Liver Conference Faculty

2024 Fees

Registration Fees

Early Bird Before 2/5/24

Regular After 2/5/24

In-person attendance (includes CME/MOC)



In-person attendance, CEU, non-CME (nurses, fellows/students, and others not requesting CME credits, research personnel)



Virtual attendance (includes CME)



Virtual attendance (does not include CME)



$175 In-person attendance (includes CME/MOC)

$125  In-person attendance, CEU, non-CME (nurses, fellows/students, and others not requesting CME credits, research personnel)

$75  Virtual attendance (includes CME)

$25  Virtual attendance (does not include CME)

$200  In-person attendance (includes CME/MOC)

$150   In-person attendance, CEU, non-CME (nurses, fellows/students, and others not requesting CME credits, research personnel)

$100  Virtual attendance (includes CME)

$50  Virtual attendance (does not include CME)

2024 Venue Information

Arizona Biltmore

2400 E. Missouri Ave., Phoenix, AZ 85016

Phone: (602) 955-6600